Haemalogix

Sydney, Australia

Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.

$7.4M raised

Sep 2021

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Haemalogix raised?

Haemalogix has raised $7.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2021.

Who are Haemalogix's investors?

Haemalogix's investors include Cicada Innovations, Platinum Asset Management.

Where is Haemalogix headquartered?

Haemalogix is headquartered in Sydney, Australia.

What does Haemalogix do?

Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.

What stage is Haemalogix at?

Haemalogix is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 8, 2021.

MLA

"Haemalogix — Funding & Investors." VCBacked, September 8, 2021, https://www.vcbacked.co/company/haemalogix. Accessed July 2, 2026.

APA

VCBacked. (2021). Haemalogix — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/haemalogix

Wikipedia (cite web)

{{cite web |title=Haemalogix — Funding & Investors |url=https://www.vcbacked.co/company/haemalogix |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 8, 2021.